Treatment of dysmenorrhea and migraine symptoms

摘要

A pharmaceutical composition for the treatment of, or for the alleviation of primary dysmenorrhea, for the treatment of acute migraine and for attaining the relaxation of smooth muscle, and a process for the treatment of the above afflictions, comprising as active ingredient a pharmaceutically active dosage of an inhibitor of prostaglandin synthetase and action. The active ingredient of choice is flufenamic acid, meferamic acid, meclofenamic acid or niflumic acid.